Clinical Trials Browser

OTHER × Lethal Congenital Contracture Syndrome 2 × In Situ Hybridization, Fluorescence × Clear all

NCT00740532 2010-09-02

Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

Lethal Congenital Contracture Syndrome 2, Breast Neoplasms